We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Electrosurgical Devices Market Driven by Rising Demand for Minimally Invasive Procedures

By HospiMedica International staff writers
Posted on 03 Apr 2023
Print article
Image: The global electrosurgical devices market is anticipated to surpass USD 10 billion by 2029 (Photo courtesy of Pexels)
Image: The global electrosurgical devices market is anticipated to surpass USD 10 billion by 2029 (Photo courtesy of Pexels)

The global electrosurgical devices market was valued at over USD 7 billion in 2022 and is expected to register a CAGR of 5% during the forecast period 2023-2029 to surpass USD 10 billion by 2029. The market expansion will be fueled by several factors, such as the increasing incidence of chronic diseases, the surge in demand for minimally invasive procedures, technological advancements and innovation in electrosurgical devices, a rise in the number of hospitals and surgeries, and a preference for outpatient surgeries in developed regions. These are the latest findings of Valuates Reports (Bangalore, India), a market research firm.

Over the past decade, there has been a notable surge in the preference for non-invasive and minimally invasive surgical procedures as compared to conventional surgical procedures. Minimally invasive surgeries provide several advantages over open surgeries, including reduced postoperative complications, shorter hospital stays, faster recovery times, higher efficiency, and less pain. Furthermore, these techniques are less costly than traditional surgical methods. In the treatment of various ailments, laser and electrosurgical technologies are increasingly preferred over traditional surgical methods, which is expected to fuel the expansion of the electrosurgical devices market.

In recent years, laparoscopic surgeries have gained popularity among patients due to various advantages, such as reduced surgical risks, minimal blood loss, lower infection risk, less pain, faster postoperative recovery, shorter hospital stays, and cost savings. Electrosurgery devices, including generators and active electrodes, enable surgeons to carry out surgeries with ease, speed, and accuracy, driving the demand for these devices. The market for electrosurgical devices is expected to grow due to increasing healthcare expenditure by developed and emerging nations for the treatment of chronic diseases. The use of electrosurgical instruments in a variety of surgeries that demand accuracy and a deadline, such as gynecological, cardiovascular, and aesthetic procedures, will further add to the market growth.

Based on type, the electrosurgical instruments segment is anticipated to be the most profitable in the electrosurgical devices market. A considerable proportion of this market is attributed to the extensive use of both disposable and reusable electrosurgical equipment. On the basis of application, the general surgery segment is projected to capture the largest market share in the electrosurgical devices market owing to the rising elderly population, the proliferation of surgical facilities, and the expansion of healthcare systems in developing countries.

Geographically, the global electrosurgical devices market is dominated by North America with the largest share. The rising incidence of chronic diseases, increasing demand for minimally invasive procedures, advancements in electrosurgical instruments, expansion of hospitals, clinics, and ambulatory surgical centers, and a growing preference for outpatient surgeries are driving the growth of the North American electrosurgical devices market.

Related Links:
Valuates Reports

Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Laser Therapy Device
IV Medication Safety Software
ICU Medical MedNet IV

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Surgical Techniques

view channel
Image: The deployable electrodes are ideal for minimally invasive craniosurgery (Photo courtesy of EPFL)

Soft Robotic Electrode Offers Minimally Invasive Solution for Craniosurgery

Minimally invasive medical procedures offer numerous benefits to patients, including decreased tissue damage and shorter recovery periods. However, creating equipment that can pass through a small opening... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.